Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Rosenthal

Showing results (181-190 of 256) with videos related to

Pageof 26
Sort By:
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
The Journal of Rheumatology|December 1, 2004
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupusPatrick Gordon, Munther A Khamashta, Eric Rosenthal, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Provocation and localization of atrial ectopy in patients with atrial septal defectsLouisa O'Neill, Iain Sim, Daniel O'Hare, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 4, 2021
High epileptiform discharge burden predicts delayed cerebral ischemia after subarachnoid hemorrhageJennifer A Kim, Wei-Long Zheng, Jonathan Elmer, et al.
BMC Health Services Research|March 14, 2012
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)Dominique Salmon-Ceron, Julien Cohen, Maria Winnock, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
JAMA|December 16, 2004
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trialFabrice Carrat, Firouzé Bani-Sadr, Stanislas Pol, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2015
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patientsPatrick Miailhes, Camille Gilbert, Karine Lacombe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 25, 2018
Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experienceGareth Morgan, Pimpak Prachasilchai, Worakan Promphan, et al.
JHEP Reports : Innovation in Hepatology|December 5, 2022
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)Fabienne Marcellin, Sylvie Brégigeon-Ronot, Clémence Ramier, et al.
Pageof 26

Showing results (181-190 of 256) with videos related to

Sort By:
Pageof 26
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
The Journal of Rheumatology|December 1, 2004
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupusPatrick Gordon, Munther A Khamashta, Eric Rosenthal, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 23, 2022
Provocation and localization of atrial ectopy in patients with atrial septal defectsLouisa O'Neill, Iain Sim, Daniel O'Hare, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 4, 2021
High epileptiform discharge burden predicts delayed cerebral ischemia after subarachnoid hemorrhageJennifer A Kim, Wei-Long Zheng, Jonathan Elmer, et al.
BMC Health Services Research|March 14, 2012
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)Dominique Salmon-Ceron, Julien Cohen, Maria Winnock, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
JAMA|December 16, 2004
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trialFabrice Carrat, Firouzé Bani-Sadr, Stanislas Pol, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2015
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patientsPatrick Miailhes, Camille Gilbert, Karine Lacombe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 25, 2018
Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experienceGareth Morgan, Pimpak Prachasilchai, Worakan Promphan, et al.
JHEP Reports : Innovation in Hepatology|December 5, 2022
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)Fabienne Marcellin, Sylvie Brégigeon-Ronot, Clémence Ramier, et al.
Pageof 26